Sort   by:  
 Page size 
TranscriptomicsAcquired resistance of Jurkat cells to TNF-related apoptosis-inducing ligand (TRAIL): a role for histone deacetylase inhibitors as powerful apoptosis sensitizer.
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to be a potent inducer of apoptosis in various cancer cell lines and primary cancer cells. However, in clinical trials administration of recombinant TRAIL or TRAIL death receptor agonists did not show sufficient efficacy ...
ORGANISM(S): Homo sapiens 
2016-06-15 | E-GEOD-38745 | biostudies-arrayexpress
UnknownDiffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options.
Not available
S-EPMC9739046 | biostudies-literature
TranscriptomicsAcquired resistance of Jurkat cells to TNF-related apoptosis-inducing ligand (TRAIL)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to be a potent inducer of apoptosis in various cancer cell lines and primary cancer cells. However, in clinical trials administration of recombinant TRAIL or TRAIL death receptor agonists did not show sufficient efficacy ...
ORGANISM(S): Homo sapiens 
2016-06-15 | E-GEOD-38743 | biostudies-arrayexpress
UnknownEighteen years' experience with tumor treating fields in the treatment of newly diagnosed glioblastoma.
Not available
S-EPMC9892904 | biostudies-literature
ProteomicsLong term adaptation of lymphoma cells to hypoxia
This study explores the long-term adaptation mechanisms of lymphoma cells subjected to hypoxic conditions, with an emphasis on the HBL2 and Ramos cell lines under normoxia and 1% O2 environments. The research methodology encompassed lysing cells using a buffer containing sodium deoxycholate and TEAB...
ORGANISM(S): Homo sapiens (Human) 
2025-02-27 | PXD050227 | Pride
Lymphoma cells (hbl2 Tmt proteomic analysis Hypoxia adaptation Ramos) Cellular mechanisms 
UnknownIbrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic.
Not available
S-EPMC9807478 | biostudies-literature
UnknownCurrent Immunotherapy Approaches in Non-Hodgkin Lymphomas.
Not available
S-EPMC7768428 | biostudies-literature
UnknownRetrospective Analysis of 118 Patients With Cutaneous T-Cell Lymphomas: A Single-Center Experience.
Not available
S-EPMC9210166 | biostudies-literature
UnknownLenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells.
Not available
S-EPMC4839314 | biostudies-literature
UnknownTargeted Drug Delivery and Theranostic Strategies in Malignant Lymphomas.
Not available
S-EPMC8833783 | biostudies-literature
Sort   by:  
 Page size